Table 2 Engraftment of donor-derived... | American Society of Hematology

Table 2

Engraftment of donor-derived cells in the injured liver of mice transplanted with either clonal cells from KSL-CD34⁻ cells or BM TNCs

Cells transplanted	Cells		CD45⁺ cells in EGFP⁺ cells, %
Cells transplanted	EGFP⁺ cells	EGFP⁺CD45⁺ cells	CD45⁺ cells in EGFP⁺ cells, %
Clonal cells
1	33.1 ± 9.9	12.6 ± 2.5	38.1
2	42.1 ± 9.8	20.0 ± 3.8	47.5
3	12.0 ± 3.4	6.3 ± 0.9	52.5
BM TNCs
1	31.6 ± 6.6	11.5 ± 3.9	37.6
2	29.2 ± 10.2	14.9 ± 4.2	51.0
3	25.9 ± 5.1	12.2 ± 2.5	47.1

Cells transplanted	Cells		CD45⁺ cells in EGFP⁺ cells, %
Cells transplanted	EGFP⁺ cells	EGFP⁺CD45⁺ cells	CD45⁺ cells in EGFP⁺ cells, %
Clonal cells
1	33.1 ± 9.9	12.6 ± 2.5	38.1
2	42.1 ± 9.8	20.0 ± 3.8	47.5
3	12.0 ± 3.4	6.3 ± 0.9	52.5
BM TNCs
1	31.6 ± 6.6	11.5 ± 3.9	37.6
2	29.2 ± 10.2	14.9 ± 4.2	51.0
3	25.9 ± 5.1	12.2 ± 2.5	47.1

Sections of livers from transplanted mice were stained for CD45. EGFP⁺ cells and EGFP⁺CD45⁺ cells were counted as described in “Immunohistochemical analysis” as the number of positive cells in each high-power field. Data represent the mean numbers of cells plus or minus the standard deviation or the percentage of CD45⁺ cells in EGFP⁺ cells.

KSL indicates Lin⁻Sca-1⁺c-kit⁺.

View Large

This Feature Is Available To Subscribers Only